All treatments
Treatment
Biological/Vaccine: Placebo clinical trials
2 indexed studies · 1 currently recruiting
- Active not recruitingPHASE3
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
This study is testing a new injection treatment for house dust mite allergy. It aims to see if it reduces allergy symptoms and is safe for adults with moderate to severe allergic rhinitis, with or without asthma. The treatment is given over one year.
For: House Dust Mite Allergy · House Dust Mite RhinitisBulgaria · Germany · Latvia - RecruitingPHASE3
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
This study is testing a new treatment called rFVIIa for a serious type of stroke caused by bleeding in the brain. It aims to see if giving this medicine quickly can improve recovery and reduce further bleeding for certain patients.
For: Intracerebral HemorrhageUnited States · Canada · Germany